Each tablet contains Cilnidipine 5 mg, 10 mg, or 20 mg.

Nulong Tablets contain Cilnidipine, a dual L/N-type calcium channel blocker indicated for the management of hypertension. Cilnidipine provides effective blood pressure control by promoting peripheral vasodilation while simultaneously suppressing sympathetic nerve activity through N-type calcium channel blockade. This dual mechanism helps achieve sustained antihypertensive effects with once-daily dosing and supports long-term cardiovascular protection.

Nulong Tablets are indicated for the treatment of mild to moderate hypertension in adult patients.

Cilnidipine is a dihydropyridine calcium channel blocker that inhibits the influx of calcium ions into vascular smooth muscle cells, resulting in vasodilation and a reduction in peripheral vascular resistance. In addition to blocking L-type calcium channels, Cilnidipine also inhibits N-type calcium channels, reducing sympathetic nerve activity and contributing to effective blood pressure reduction. This dual mechanism provides sustained antihypertensive efficacy while reducing cardiovascular workload.

Cilnidipine is a dihydropyridine calcium channel blocker that inhibits the influx of calcium ions into vascular smooth muscle cells, resulting in vasodilation and a reduction in peripheral vascular resistance. In addition to blocking L-type calcium channels, Cilnidipine also inhibits N-type calcium channels, reducing sympathetic nerve activity and contributing to effective blood pressure reduction. This dual mechanism provides sustained antihypertensive efficacy while reducing cardiovascular workload.

Nulong Tablets are contraindicated in patients with known hypersensitivity to Cilnidipine or any component of the formulation and in patients with aortic stenosis.